ORCAS INTERNATIONAL, INC. – Trademark Portfolio
Entity Type: 03
ORCAS INTERNATIONAL, INC. holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 14 trademarks are registered. Notable registered marks include BCM-95, AMLAMAX, BOSPURE, MORINGAN, and PRODOZIN. The owner is based in Hackettstown, NJ.
64 Mallard Drive
Hackettstown, NJ 07840
Showing of trademarks Trademarks
Trademark Classifications
ORCAS INTERNATIONAL, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ORCAS INTERNATIONAL, INC. have?
ORCAS INTERNATIONAL, INC. has 27 U.S. trademarks filed with the USPTO. Of these, 14 registered, 2 abandoned, 11 cancelled.
What trademark classes does ORCAS INTERNATIONAL, INC. file in?
ORCAS INTERNATIONAL, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ORCAS INTERNATIONAL, INC.'s most well-known trademarks?
ORCAS INTERNATIONAL, INC.'s registered trademark portfolio includes well-known marks such as BCM-95, AMLAMAX, BOSPURE, MORINGAN, and PRODOZIN. These are among 14 currently registered trademarks in the portfolio.
What is ORCAS INTERNATIONAL, INC.'s trademark registration success rate?
ORCAS INTERNATIONAL, INC. has a 52% trademark registration rate, with 14 out of 27 resolved applications resulting in successful registration. Currently, 0 applications are pending review.